SEARCH

SEARCH BY CITATION

References

  • 1
    van Ampting JM, Penne EL, Beek FJ et al. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant 2003;18:11471151.
  • 2
    Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001;37:11841190.
  • 3
    Morigi M, Introna M, Imberti B et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008;26:20752082.
  • 4
    Togel F, Cohen A, Zhang P et al. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 2009;18:475485.
  • 5
    Ninichuk V, Gross O, Segerer S et al. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int 2006;70:121129.
  • 6
    Semedo P, Correa-Costa M, Antonio Cenedeze M et al. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells 2009;27:30633073.
  • 7
    Bianco P, Cao X, Frenette PS et al. The meaning, the sense and the significance: Translating the science of mesenchymal stem cells into medicine. Nat Med 2013;19:3542.
  • 8
    Eltzschig HK, Eckle T. Ischemia and reperfusion—From mechanism to translation. Nat Med 2011;17:13911401.
  • 9
    Cantaluppi V, Biancone L, Quercia A et al. Rationale of mesenchymal stem cell therapy in kidney injury. Am J Kidney Dis 2013;61:300309.
  • 10
    Zhu XY, Urbieta-Caceres V, Krier JD et al. Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms. Stem Cells 2013;31:117125.
  • 11
    Hara Y, Stolk M, Ringe J et al. In vivo effect of bone marrow-derived mesenchymal stem cells in a rat kidney transplantation model with prolonged cold ischemia. Transpl Int 2011;24:11121123.
  • 12
    Tan J, Wu W, Xu X et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial. JAMA 2012;307:11691177.
  • 13
    Chang CL, Leu S, Sung HC et al. Impact of apoptotic adipose-derived mesenchymal stem cells on attenuating organ damage and reducing mortality in Rat sepsis syndrome induced by cecal puncture and ligation. J Transl Med 2012;10:244.
  • 14
    Yagi H, Soto-Gutierrez A, Kitagawa Y et al. Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant 2010;19:823830.
  • 15
    Kim JH, Park DJ, Yun JC et al. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am J Physiol Renal Physiol 2012;302:F11411150.
  • 16
    Westenfelder C, Togel FE. Protective actions of administrated mesenchymal stem cells in acute kidney injury: Relevance to clinical trials. Kidney Int Suppl 2011;1:103106.
  • 17
    Zhu XY, Chade AR, Krier JD et al. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 2009;27:20632073.
  • 18
    Zhu XY, Chade AR, Rodriguez-Porcel M et al. Cortical microvascular remodeling in the stenotic kidney: Role of increased oxidative stress. Arterioscler Thromb Vasc Biol 2004;24:18541859.
  • 19
    Liu H, Liu S, Li Y et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. Plos One 2012;7:e34608.
  • 20
    Herrera MB, Bussolati B, Bruno S et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 2007;72:430441.
  • 21
    Togel F, Isaac J, Hu Z et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005;67:17721784.
  • 22
    Bruno S, Grange C, Deregibus MC et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20:10531067.
  • 23
    Gatti S, Bruno S, Deregibus MC et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 2011;26:14741483.
  • 24
    Hagiwara M, Shen B, Chao L et al. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 2008;19:807819.
  • 25
    Humphreys BD, Czerniak S, DiRocco DP et al. Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci USA 2011;108:92269231.
  • 26
    Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008;2:284291.
  • 27
    Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005;115:17561764.
  • 28
    Togel F, Weiss K, Yang Y et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007;292:F16261635.
  • 29
    Morigi M, Imberti B, Zoja C et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004;15:17941804.
  • 30
    Chade AR, Zhu X, Lavi R et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation 2009;119:547557.
  • 31
    Wheatley K, Ives N, Gray R et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:19531962.
  • 32
    Eirin A, Zhu XY, Krier JD et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 2012;30:10301041.
  • 33
    Fang Y, Tian X, Bai S et al. Autologous transplantation of adipose-derived mesenchymal stem cells ameliorates streptozotocin-induced diabetic nephropathy in rats by inhibiting oxidative stress, pro-inflammatory cytokines and the p38 MAPK signaling pathway. Int J Mol Med 2012;30:8592.
  • 34
    Devine SM, Cobbs C, Jennings M et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003;101:29993001.
  • 35
    Fischer UM, Harting MT, Jimenez F et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev 2009;18:683692.
  • 36
    Zonta S, De Martino M, Bedino G et al. Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: Endovenous or arterial? Transplant Proc 2010;42:13361340.
  • 37
    Zhuo W, Liao L, Fu Y et al. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats. Transplant Proc 2013;45:503510.
  • 38
    Alfarano C, Roubeix C, Chaaya R et al. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Cell Transplant 2012;21:20092019.
  • 39
    Thirabanjasak D, Tantiwongse K, Thorner PS. Angiomyeloproliferative lesions following autologous stem cell therapy. J Am Soc Nephrol 2010;21:12181222.
  • 40
    van Koppen A, Joles JA, van Balkom BW et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. Plos One 2012;7:e38746.
  • 41
    Reis LA, Borges FT, Simoes MJ et al. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. Plos One 2012;7:e44092.
  • 42
    Lee SR, Lee SH, Moon JY et al. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren Fail 2010;32:840848.